{"title":"经导管主动脉瓣置入术中金属丝损伤致左室假性动脉瘤的评估与治疗1例。","authors":"Fumiko Yoshimachi, Tomohiko Shindo, Shigeo Godo, Kiyotaka Hao, Takashi Shiroto, Jun Takahashi, Satoshi Yasuda","doi":"10.3389/fcvm.2025.1676337","DOIUrl":null,"url":null,"abstract":"<p><p>Transcatheter aortic valve implantation (TAVI) has recently become a minimally invasive alternative to surgical aortic valve replacement. However, it remains associated with potentially life-threatening complications. Among these, left ventricular pseudoaneurysm is a rare but serious event. Although infrequently reported, its occurrence may be followed by rapid clinical deterioration and fatal outcomes. We report the case of an 84-year-old woman with severe aortic stenosis (AS), who developed a left ventricular pseudoaneurysm following TAVI. Pre-procedural echocardiography showed a heavily calcified and immobile aortic valve, with a peak velocity of 4.0 m/s, an aortic valve area of 1.17 cm², and a mean pressure gradient of 38 mmHg. A self-expandable valve was selected to optimize supra-annular deployment. One day after the procedure, imaging revealed a pseudoaneurysm at the left ventricular apex. This case highlights a rare but critical complication of TAVI. We discuss potential mechanisms, preventive considerations, and management strategies for such events.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1676337"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497713/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessment and treatment of left ventricular pseudoaneurysm due to wire injury in transcatheter aortic valve implantation: a case report.\",\"authors\":\"Fumiko Yoshimachi, Tomohiko Shindo, Shigeo Godo, Kiyotaka Hao, Takashi Shiroto, Jun Takahashi, Satoshi Yasuda\",\"doi\":\"10.3389/fcvm.2025.1676337\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Transcatheter aortic valve implantation (TAVI) has recently become a minimally invasive alternative to surgical aortic valve replacement. However, it remains associated with potentially life-threatening complications. Among these, left ventricular pseudoaneurysm is a rare but serious event. Although infrequently reported, its occurrence may be followed by rapid clinical deterioration and fatal outcomes. We report the case of an 84-year-old woman with severe aortic stenosis (AS), who developed a left ventricular pseudoaneurysm following TAVI. Pre-procedural echocardiography showed a heavily calcified and immobile aortic valve, with a peak velocity of 4.0 m/s, an aortic valve area of 1.17 cm², and a mean pressure gradient of 38 mmHg. A self-expandable valve was selected to optimize supra-annular deployment. One day after the procedure, imaging revealed a pseudoaneurysm at the left ventricular apex. This case highlights a rare but critical complication of TAVI. We discuss potential mechanisms, preventive considerations, and management strategies for such events.</p>\",\"PeriodicalId\":12414,\"journal\":{\"name\":\"Frontiers in Cardiovascular Medicine\",\"volume\":\"12 \",\"pages\":\"1676337\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497713/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Cardiovascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fcvm.2025.1676337\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1676337","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Assessment and treatment of left ventricular pseudoaneurysm due to wire injury in transcatheter aortic valve implantation: a case report.
Transcatheter aortic valve implantation (TAVI) has recently become a minimally invasive alternative to surgical aortic valve replacement. However, it remains associated with potentially life-threatening complications. Among these, left ventricular pseudoaneurysm is a rare but serious event. Although infrequently reported, its occurrence may be followed by rapid clinical deterioration and fatal outcomes. We report the case of an 84-year-old woman with severe aortic stenosis (AS), who developed a left ventricular pseudoaneurysm following TAVI. Pre-procedural echocardiography showed a heavily calcified and immobile aortic valve, with a peak velocity of 4.0 m/s, an aortic valve area of 1.17 cm², and a mean pressure gradient of 38 mmHg. A self-expandable valve was selected to optimize supra-annular deployment. One day after the procedure, imaging revealed a pseudoaneurysm at the left ventricular apex. This case highlights a rare but critical complication of TAVI. We discuss potential mechanisms, preventive considerations, and management strategies for such events.
期刊介绍:
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.